MEDIROM Healthcare Technologies (MRM) Stock Price, News & Analysis

Company Overview

MEDIROM Healthcare Technologies Inc. provides holistic healthcare services in Japan. It operates in three segments: Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty. The Relaxation Salon segment owns and franchises relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology. This segment operates relaxation salons under the Re.Ra.Ku and Ruam Ruam brands. The Digital Preventative Healthcare segment offers government-sponsored Specific Health Guidance program, utilizing Lav, an on-demand health monitoring smartphone application and MOTHER Bracelet for fitness applications; and preventative healthcare services utilizing nutritionists and health nurses. The Luxury Beauty segment manages and operates hair salons under the ZACC brand name. MEDIROM Healthcare Technologies Inc. also operates Re.Ra.Ku College that offers continuing training for franchise owners, home office staff, and salon staff covering topics, such as customer service, salon operations, and relaxation techniques. The company was formerly known as MEDIROM Inc. and changed its name to MEDIROM Healthcare Technologies Inc. in March 2020. MEDIROM Healthcare Technologies Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.

Key Stats

• Today's Range: $1.35 to $1.45
• 50-Day Range: $0.79 to $1.78
• 52-Week Range: $0.34 to $8.39
• Volume: 19,905 shs
• Average Volume: 704,039 shs
• Market Capitalization: $39.40 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Strong Buy

MEDIROM Healthcare Technologies Stock Analysis - MarketRank™

MEDIROM Healthcare Technologies scored higher than 14% of companies evaluated by MarketBeat, and ranked 889th out of 933 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for MEDIROM Healthcare Technologies.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

MEDIROM Healthcare Technologies has a P/B Ratio of 4.48. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.59% of the float of MEDIROM Healthcare Technologies has been sold short.

Short Interest Ratio / Days to Cover

MEDIROM Healthcare Technologies has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in MEDIROM Healthcare Technologies has recently decreased by 40.27%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

MEDIROM Healthcare Technologies does not currently pay a dividend.

Dividend Growth

MEDIROM Healthcare Technologies does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.59% of the float of MEDIROM Healthcare Technologies has been sold short.

Short Interest Ratio / Days to Cover

MEDIROM Healthcare Technologies has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in MEDIROM Healthcare Technologies has recently decreased by 40.27%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for MEDIROM Healthcare Technologies this week, compared to 1 article on an average week.

MarketBeat Follows

1 people have added MEDIROM Healthcare Technologies to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, MEDIROM Healthcare Technologies insiders have not sold or bought any company stock.

Percentage Held by Insiders

40.24% of the stock of MEDIROM Healthcare Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.

MRM Stock Analysis - Frequently Asked Questions

How have MRM shares performed this year?

MEDIROM Healthcare Technologies' stock was trading at $1.03 at the start of the year. Since then, MRM shares have increased by 34.8% and is now trading at $1.3881.

When did MEDIROM Healthcare Technologies IPO?

MEDIROM Healthcare Technologies (MRM) raised $12 million in an initial public offering on Tuesday, December 29th 2020. The company issued 800,000 shares at $15.00 per share. Maxim Group LLC acted as the underwriter for the IPO.

How do I buy shares of MEDIROM Healthcare Technologies?

Shares of MRM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of MEDIROM Healthcare Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that MEDIROM Healthcare Technologies investors own include NVIDIA (NVDA), Broadcom (AVGO), Adobe (ADBE), Arista Networks (ANET), AppLovin (APP), e.l.f. Beauty (ELF) and Disc Medicine (IRON).

Company Calendar

• Today: 7/19/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Personal services
• Sub-Industry: Personal Services
• Current Symbol: NYSE:MRM
• CIK: 1819704
• Web: medirom.co.jp
• Phone: 813-6721-7364
• Fax: N/A
• Employees: 480
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.34
• Quick Ratio: 0.29

Sales & Book Value

• Annual Sales: $8.30 billion
• Price / Sales: 0.00
• Cash Flow: $0.93 per share
• Price / Cash Flow: 1.49
• Book Value: $0.31 per share
• Price / Book: 4.48

Miscellaneous

• Outstanding Shares: 28,387,000
• Free Float: 2,951,000
• Market Cap: $39.40 million
• Optionable: Not Optionable
• Beta: 0.89